caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1033311287

John MillsM.D.

Infectious DiseaseNew Brunswick, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where John Mills's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
REGENTS OF THE UNIVERSITY OF MICHIGAN1350
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
12
Beneficiaries
—
Total drug cost
$48K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala12 claims
QUALITY · MIPS · 2024
Final MIPS score
88.4
Quality
70.6
Cost
69.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.56%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 310038
Hospital
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$30
Payment records
1
By payment type
Food and Beverage$30
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
144
Unique beneficiaries
—
Total services
192
Distinct HCPCS
5
Medicare payment
$17K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 261 Infectious Disease providers in NJ — bottom quintile (cohort median 1,368).